Anti-CD40 antibodies

Details for Australian Patent Application No. 2011235214 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Barrett, Rachel; Brodeur, Scott; Canada, Keith A.; Litzenburger, Tobias; Singh, Sanjaya

Agent Spruson & Ferguson

Pub. Number AU-A-2011235214

PCT Pub. Number WO2011/123489

Priority 61/319,574 31.03.10 US

Filing date 30 March 2011

Wipo publication date 6 October 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 27/00 Drugs for disorders of the senses

A61P 37/00 Drugs for immunological or allergic disorders

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/123489 Priority application(s): WO2011/123489

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235220-Influenza virus vaccines and uses thereof

2011235212-Reprogramming cells